Activity Preview

Live

FOCUS Quiz: Spring 2020 - Challenges of Mood Disorders Care

Activity Type:

  • Journal CME


Release Date: 4/1/2020

Expiration Date: 12/31/2022

  • AMA PRA Category 1: 5
  • Participation: 5

Register

Overview

Challenges of Mood Disorders Care

FOCUS, APA's clinical review and continuing medical education journal, is designed as a personal study resource to help practicing psychiatrists keep abreast of significant advances in the field, with particular attention to clinical practice and incorporation of core competencies. The goal of FOCUS is the dissemination of up-to-date clinical information, facilitation of lifelong learning skills, maintenance of certification, and opportunity for self-assessment in order to improve patient care. Each issue, prepared by distinguished faculty who are recognized in their fields, provides up to date clinical information and incorporates a CME component. The material can be used effectively by establishing a regular schedule of study.

Pricing

This activity is only available to 2020 Focus subscribers.

Don't have a subscription to 2020 Focus? Subscribe online or by phone at 1-800-368-5777.  

If you have questions about Focus subscriptions, please contact appi@psych.org.

Educational Objective

This issue of Focus provides the reader with a current view of evidence-based principles for mood disorder treatment

Participants will

  • Explore the clinical challenge related to stopping effective antidepressant treatments
  • Incorporate clinical care recommendations on the complexities of managing mood disorders in adults and in specific populations such as adolescents, postpartum patients, patients with SUD, and in patients with depression occurring with neurological impairment
  • Consider the efficacy of integrating technology into clinical care
  • Identify next steps after a patient with “treatment-resistant depression” responds to ketamine
  • Incorporate suicide risk assessment into clinical care

Target Audience

This program is one element of a lifelong learning program for physicians.

Estimated Time to Complete

Estimated Duration: 5 hours
Begin Date: April 1, 2020
End Date: December 31, 2022

How to Earn Credit

In order to earn CME credit, participants should read through the material presented in the issue. After reading the materials, complete the CME quiz by answering multiple-choice questions with a single correct answer. A score of 60% or higher is required to receive credit. Retakes are available for the test. Review the rationales, complete the online course evaluation, and then claim and print your CME certificate. The APA provides a CME certificate of credit for physicians and a certificate of participation for non-physicians.

Accreditation

The American Psychiatric Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

The APA designates this journal-based CME activity for a maximum of 5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Faculty and Planner Disclosures

Program Planners – Editor and Section Editors

Mark H. Rapaport,  MD, Editor of FOCUS, and Chairman and Chief of Psychiatric Services, Department of Psychiatry and Behavioral Sciences, Emory University School of Medicine, Atlanta, Ga. No financial relationships with commercial interests.

Dorothy Stubbe, MD, Editor and Author, Communications Commentary, Associate Professor and Program Director, Yale University School of Medicine Child Study Center, New Haven, CT.- No financial relationships with commercial interests.

Laura Dunn,  MD, Editor Ethics Column; Department of Psychiatry and Behavioral Sciences, Stanford University School of Medicine, Stanford, CA; No financial relationships with commercial interests.

Boadie Dunlop, M.D., Editor, Applied Armamentarium section, Associate Professor of Psychiatry and Behavioral Sciences, Emory University School of Medicine, Director, Mood and Anxiety Disorders Program, Emory University School of Medicine. Dr. Dunlop reports: Consultant: Myriad Neuroscience, Sophren Therapeutics. Grant/Research: Acadia, Aptinyx, Intracellular Therapies, Takeda, Compass Pathways, Sage.

Ian Cook, M.D. Section Editor/author,  Patient Management Exercise, Postpartum Depression. Semel Institute for Neuroscience and Human Behavior, University of California, Los Angeles, and Los Angeles TMS Institute. Dr. Cook reports that the University of California, Los Angeles (UCLA), received research grant funding from NeoSync, Inc., for his work there prior to retirement and that his active biomedical device patents are assigned to the University of California. He has been granted stock options in NeuroSigma, the licensee of some of his inventions, and he currently is on leave as its chief medical officer and senior vice president. Dr. Cook has equity positions and leadership roles in HeartCloud, Inc., and the BrainCloud Corporation.

Authors and Guest Editors

Consequences of Recurrence of Major Depressive Disorder: Is Stopping Effective Antidepressant Medications Ever Safe?

Jennifer Severe, M.D., John F. Greden, M.D., Priyanka Reddy, Department of Psychiatry, University of Michigan, Ann Arbor.  Dr. Greden reports serving on advisory boards or speaker bureaus or as an expert witness or consultant for Clarigent Health, Med-IQ, Inc., Palmetto GBA (MolDX Program), and Sage Therapeutics. The other authors report no financial relationships with commercial interests.

Depression Comorbid with Stroke, Traumatic Brain Injury, Parkinson’s Disease, and Multiple Sclerosis: Diagnosis and Treatment

Susan K. Conroy, M.D., Ph.D., Katherine B. Brownlowe, M.D., Thomas W. McAllister, M.D.Department of Psychiatry, Indiana University School of Medicine, Indianapolis (Conroy, McAllister); Department of Psychiatry, Wexner Medical Center, Ohio State University, Columbus (Brownlowe).  Dr. McAllister receives research funding from the National Institutes ofHealth, the U.S. Department of Defense, and the National CollegiateAthletic Association. Dr. Conroy reports that her spouse was employed by Eli Lilly and Company until 2019. Dr. Brownlowe reports no financial relationships with commercial interests.

 Care of Patients with Complex Mood Disorders

Zachary A. Cordner, M.D., Ph.D., Dean F. MacKinnon, M.D., J. Raymond DePaulo Jr., M.D., Department of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine, Baltimore (Cordner, MacKinnon, DePaulo). Dr. DePaulo serves as an unpaid consultant for Assurex Health, Inc. on behalf of the National Network of Depression Centers (NNDC), which is compensated for his consultation; he holds stock in CVS Health; he has a fiduciary but unpaid relationship with the NNDC as Chairperson of the Board of Directors, and he receives travel reimbursement from the NNDC (about $2,500 per year). The other authors report no financial relationships with commercial interests.

 Computer-Assisted CBT and Mobile Apps for Depression: Assessment and Integration Into Clinical Care

Jesse H. Wright, M.D., Ph.D., and Matthew Mishkind, Ph.D., Department of Psychiatry and Behavioral Sciences, University of Louisville School of Medicine, Louisville, Kentucky (Wright); Johnson Depression Center, Department of Family Medicine, University of Colorado School of Medicine, Aurora (Mishkind). Dr. Wright is an author of the Good Days Ahead program and has an equity interest in Empower Interactive and Mindstreet, developers and distributors of the program. He receives no income from program sales. He also reports receipt of book royalties from American Psychiatric Press, Inc., Guilford Press, and Simon and Schuster and receipt of grant support from the Agency for Healthcare Research and Quality and the Oticon Foundation. Dr. Mishkind reports receipt of payments for service on an advisory board for Meta Pro.

Suicide Risk Assessment and Prevention: Challenges and Opportunities

Eileen P. Ryan, D.O., and Maria A. Oquendo, M.D., Ph.D., Department of Psychiatry and Behavioral Health, Ohio State University

College of Medicine, Columbus (Ryan); and Perelman School of Medicine, University of Pennsylvania, Philadelphia (Oquendo).  Dr. Ryan receives royalties from Oxford University Press and honoraria from the American Physicians Institute and Northwestern University (Grand Rounds). Dr. Oquendo receives royalties for the commercial use of the Columbia Suicide Severity Rating Scale and owns shares in Mantra, Inc. Her family owns stock in Bristol-Myers Squibb.

Is Postpartum Depression Different from Depression Occurring Outside of the Perinatal Period? A Review of the Evidence

Melissa M. Batt, M.D., M.P.H., Korrina A. Duffy, Ph.D., Andrew M. Novick, M.D., Ph.D., Christina A. Metcalf, Ph.D., C. Neill Epperson, M.D., Department of Psychiatry (all authors) and Helen and Arthur E. Johnson Depression Center (Batt), University of Colorado School of Medicine, Anschutz Medical Campus, Aurora.  Dr. Epperson reports that she consults to Sage Therapeutics and serves on the advisory board of Asarina Pharma. She has investments in Abbott, Abbvie, Johnson and Johnson, Merck, and Pfizer. The other authors report no financial relationships with commercial interests.

 Advancing Treatment of Depression and Other Mood Disorders Through Innovative Models of Telepsychiatry

Jay H. Shore, M.D., M.P.H., Christopher D. Schneck, M.D., Matthew Mishkind, Ph.D., Robert Caudill, M.D., Marshal Thomas, M.D. Helen and Arthur E Johnson Depression Center, School of Medicine, University of Colorado, Anschutz Medical Campus, Aurora (Shore, Schneck, Mishkind, Thomas); AccessCare, Aurora, Colorado (Shore, Thomas); Department of Psychiatry and Behavioral Sciences, University of Louisville, School of Medicine, Louisville, Kentucky (Caudill). Dr. Shore is chief medical officer of AccessCare, a provider of telemental health services, and has received royalties from Springer Publishing and from American Psychiatric Association Publishing. Dr. Mishkind reports serving on an advisory board for MetaPro. The other authors report no financial relationships with commercial interests.

Management of Complex Co-occurring Psychiatric Disorders and High-Risk Behaviors in Adolescents

Justine W. Welsh, M.D., Maggie Mataczynski, B.A., Dana B. Sarvey, M.D., Jessica E. Zoltani, M.D. Department of Psychiatry and Behavioral Sciences, Emory University School of Medicine, Atlanta (Welsh and Mataczynski); Adolescent Acute Residential Treatment, McLean Hospital, Harvard Medical School, Belmont, Massachusetts (Sarvey); Yale New Haven Psychiatric Hospital, Yale School of Medicine, New Haven, Connecticut (Zoltani). Dr. Welsh has received consulting fees from Analgesic Solutions and training fees from Chestnut Health Systems. The other authors report no financial relationships with commercial interests.

Next-Step Treatment Considerations for Patients with Treatment-Resistant Depression That Responds to Low-Dose Intravenous Ketamine

William V. Bobo, M.D., M.P.H., Patricio Riva-Posse, M.D., Fernando S. Goes, M.D., Sagar V. Parikh, M.D. Department of Psychiatry and Psychology, Mayo Clinic, Jacksonville, Florida (Bobo); Department of Psychiatry and Behavioral Sciences, Emory University, Atlanta (Riva-Posse); Department of Psychiatry and Behavioral Science, Johns Hopkins University School of Medicine, Baltimore (Goes); Department of Psychiatry, University of Michigan, Ann Arbor (Parikh). Dr. Riva-Posse served on an advisory board for Janssen Pharmaceuticals. Dr. Goes has received research support from Janssen Pharmaceuticals. Dr. Parikh has received research support from Assurex, Sage, and Takeda; has served as a consultant for Assurex, Janssen, Mensante, and Takeda; and owns shares of Mensante. Dr. Bobo reports no financial relationships with commercial interests.

Ethics Commentary: Ethical Issues in the Evaluation and Treatment of Depression

Alissa Megan Rogol, M.D., J.D., Department of Psychiatry and Behavioral Sciences, Stanford University, Stanford, California. Dr. Rogol reports no financial relationships with commercial interests.

American Psychiatric Association Staff Involved in Planning: 

Tristan Gorrindo,  MD  Director, Division of Education, APA – no conflicts

Kristen Moeller, Director of CME, Associate Director of FOCUS -- no conflicts   

Hardware/Software Requirements

Hardware/Software Requirements
This internet-based CME activity is best experienced using Internet Explorer 8+, Mozilla Firefox 3+, Safari 4+. This Web site requires that JavaScript and session cookies be enabled. Certain activities may require additional software to view multimedia, presentation, or printable versions of the content. These activities will be marked as such and will provide links to the required software. That software may be: Adobe Flash, Adobe Acrobat, Microsoft PowerPoint, and Windows Media Player.

Optimal System Configuration

  • Flash Player: Adobe Flash Player 10.1+ 
  • Browser: Firefox 3+, Internet Explorer 8.0+, Safari 4.0+, or Google Chrome 7.0+ 
  • Operating System: Windows XP+ or Mac OS X 10.4+ 
  • Internet Connection: 1 Mbps or higher

Minimum Requirements

Windows PC:
500-MHz Pentium II; Windows XP or higher; 128 MB RAM; Video Card at least 64MB of video memory; Sound Card at least 16-bit; Macromedia Flash Player 10 or higher, audio playback with speakers for programs with video content; Firefox 1.1+, Internet Explorer 7.0+, Safari 1.0+, Google Chrome, or Opera

Macintosh:
Mac OS X 10.3 or higher with latest updates installed; 1.83MHz Intel Core Duo or faster; RAM: 128MB or more; Video Card: at least 64MB of video memory; Sound Card: at least 16-bit

For assistance: Contact educme@psych.org for questions about this course | Contact learningcenter@psych.org for technical assistance

Register